Market Overview

Benzinga's Top Upgrades, Downgrades For March 11, 2019

Share:

Top Upgrades

  • Analysts at Bank of America upgraded Apple Inc. (NASDAQ: AAPL) from Neutral to Buy. Apple rose 1.6 percent to $175.62 in pre-market trading.
  • Nomura upgraded Facebook, Inc. (NASDAQ: FB) from Neutral to Buy. Facebook shares rose 1.3 percent to $171.84 in pre-market trading.
  • Barclays upgraded Spirit Airlines Incorporated (NYSE: SAVE) from Equal-Weight to Overweight. Spirit Airlines shares rose 0.6 percent to $51.99 in pre-market trading.
  • Analysts at JP Morgan upgraded FireEye Inc (NASDAQ: FEYE) from Neutral to Overweight. FireEye shares rose 4.4 percent to $16.80 in pre-market trading.
  • Jefferies upgraded Nutanix Inc (NASDAQ: NTNX) from Hold to Buy. Nutanix shares rose 2.4 percent to $35.31 in pre-market trading.
  • MKM Partners upgraded Infinera Corp. (NASDAQ: INFN) from Neutral to Buy. Infinera shares fell 1.52 percent to close at $4.54 on Friday.
  • Jefferies upgraded China Mobile Ltd. (NYSE: CHL) from Hold to Buy. China Mobile shares rose 0.46 percent to close at $ 51.86 on Friday.
  • Analysts at BMO Capital upgraded Weyerhaeuser Co (NYSE: WY) from Market Perform to Outperform. Weyerhaeuser shares rose 1.7 percent to $25.08 in pre-market trading.
  • KeyBanc upgraded PGT Innovations Inc (NYSE: PGTI) from Sector Weight to Overweight. PGT Innovations shares rose 2.6 percent to $14.53 in pre-market trading.
  • First Analysis upgraded Tabula Rasa HealthCare Inc (NASDAQ: TRHC) from Outperform to Strong Buy. Tabula Rasa HealthCare shares gained 1.53 percent to close at $58.33 on Friday.

 

Top Downgrades

  • Barclays downgraded JetBlue Airways Corporation (NASDAQ: JBLU) from Overweight to Equal-Weight. JetBlue shares fell 1.7 percent to $15.80 in pre-market trading.
  • Nomura downgraded Oracle Corporation (NYSE: ORCL) from Buy to Reduce. Oracle shares fell 2 percent to $51.75 in pre-market trading.
  • Morgan Stanley downgraded SunTrust Banks, Inc. (NYSE: STI) from Overweight to Equal-Weight. SunTrust shares fell 0.03 percent to $63.47 in pre-market trading.
  • KeyBanc downgraded Greenbrier Companies Inc (NYSE: GBX) from Overweight to Sector Weight. Greenbrier shares rose 0.72 percent to close at $38.93 on Friday.
  • JP Morgan downgraded Orion Engineered Carbons SA (NYSE: OEC) from Overweight to Neutral. Orion Engineered Carbons shares fell 17.77 percent to close at $21.80 on Friday.
  • Goldman Sachs downgraded UDR, Inc. (NYSE: UDR) from Neutral to Sell. UDR shares rose 0.52 percent to close at $44.89 on Friday.
  • Pivotal Research downgraded Zumiez Inc. (NASDAQ: ZUMZ) from Buy to Hold. Zumiez shares fell 2.5 percent to $24.00 in pre-market trading.
  • Jefferies downgraded China Biologic Products Holdings Inc (NASDAQ: CBPO) from Hold to Underperform. China Biologic Products shares fell 0.93 percent to close at $82.83 on Friday.
  • BMO Capital downgraded Cronos Group Inc (NASDAQ: CRON) from Market Perform to Underperform. Cronos shares fell 1.4 percent to $21.43 in pre-market trading.
  • SunTrust Robinson Humphrey downgraded American Renal Associates Holdings Inc (NYSE: ARA) from Buy to Hold. American Renal Associates shares fell 16.65 percent to close at $10.46 on Friday.

 

Top Initiations

  • Analysts at Goldman Sachs initiated coverage on Schlumberger Limited (NYSE: SLB) with a Buy rating. The price target for Schlumberger is set to $55. Schlumberger shares closed at $41.29 on Friday.
  • Wedbush initiated coverage on TCR2 Therapeutics Inc. (NASDAQ: TCRR) with an Outperform rating. The price target for TCR2 Therapeutics is set to $28. TCR2 Therapeutics shares closed at $15.64 on Friday.
  • H.C. Wainwright initiated coverage on Aileron Therapeutics Inc (NASDAQ: ALRN) with a Buy rating. The price target for Aileron Therapeutics is set to $7. Aileron Therapeutics shares closed at $1.45 on Friday.
  • Analysts at Goldman Sachs initiated coverage on RPC, Inc. (NYSE: RES) with a Sell rating. The price target for RPC is set to $10. RPC shares closed at $9.67 on Friday.
  • JP Morgan initiated coverage on Avedro Inc (NASDAQ: AVDR) with an Overweight rating. The price target for Avedro is set to $16. Avedro shares closed at $11.70 on Friday.
  • Compass Point initiated coverage on Raymond James Financial, Inc. (NYSE: RJF) with a Buy rating. The price target for Raymond James Financial is set to $96. Raymond James Financial shares closed at $80.35 on Friday.
  • Analysts at Barclays initiated coverage on CytomX Therapeutics Inc (NASDAQ: CTMX) with an Overweight rating. CytomX Therapeutics shares closed at $9.50 on Friday.
  • Barclays initiated coverage on Cloudera Inc (NYSE: CLDR) with an Equal-Weight rating. The price target for Cloudera is set to $16. Cloudera shares closed at $13.83 on Friday.
  • Analysts at Goldman Sachs initiated coverage on Halliburton Company (NYSE: HAL) with a Buy rating. Halliburton shares closed at $27.47 on Friday.
  • H.C. Wainwright initiated coverage on Co-Diagnostics Inc (NASDAQ: CODX) with a Buy rating. The price target for Co-Diagnostics is set to $2. Co-Diagnostics shares closed at $1.20 on Friday.

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

 

Related Articles (AAPL + ALRN)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
DGXMaintains99.0
KOMaintains52.0
WATMaintains230.0
TWTRMaintains46.0
SNAPMaintains8.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Bank Of America Upgrades Apple To Buy, Says Street Is Too Pessimistic

How Much You Need To Earn To Buy A Home In America Today